North York Diagnostic and Cardiac Centre
North York, Ontario, Canada
Medical center in Toronto, Ontario
250 Marlee Ave, North York, ON M6B 1N6
About North York Diagnostic and Cardiac Centre
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Canadian Medical and Surgical Knowledge Translation Research Group
4
Eli Lilly and Company
4
Boehringer Ingelheim
2
Pfizer
2
Amgen
1
Bayer
1
Unity Health Toronto
1
Clinical Trials at North York Diagnostic and Cardiac Centre
During the past decade, North York Diagnostic and Cardiac Centre conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
2017-03-02
2021-04-26
Completed
5,988
EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
2017-03-06
2020-05-28
Completed
3,730
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
2020-05-29
2024-10-17
Active, not recruiting
13,299
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
Empagliflozin and Cardiac Remodelling in People Without Diabetes
2021-04-01
2022-07-31
Completed
169
A Study of Evolocumab on Carotid Artery Atherosclerotic Plaque Morphology Prior to Carotid EndArterectomy
2020-08-28
2022-05-01
Recruiting
60
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "North York Diagnostic and Cardiac Centre" #1 sponsor was "Canadian Medical and Surgical Knowledge Translation Research Group" with 4 trials, followed by "Eli Lilly and Company" with 4 trials
sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "North York Diagnostic and Cardiac Centre"
#1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "HLS Therapeutics, Inc" with 2 trials as a collaborator, "Unity Health Toronto" with 2 trials as a collaborator, "Western University, Canada" with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at North York Diagnostic and Cardiac Centre
According to Clinical.Site data, the most researched conditions in "North York Diagnostic and Cardiac Centre" are
"Heart Failure" (5 trials), "Cardiovascular Diseases" (4 trials), "Dyslipidemias" (2 trials), "Asymptomatic Carotid Artery Stenosis" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "North York Diagnostic and Cardiac Centre" in a lesser frequency.
Clinical Trials Intervention Types at North York Diagnostic and Cardiac Centre
Most popular intervention types in "North York Diagnostic and Cardiac Centre" are "Drug" (13 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (9 trials), "Empagliflozin" (3 trials), "Evolocumab" (2 trials), "Tirzepatide" (2 trials) and "Dulaglutide" (1 trials). Other intervention names were less common.
Clinical Trials Genders at North York Diagnostic and Cardiac Centre
The vast majority of trials in "North York Diagnostic and Cardiac Centre" are
15 trials for "All" genders.
Clinical Trials Status at North York Diagnostic and Cardiac Centre
Currently, there are NaN active trials in "North York Diagnostic and Cardiac Centre".
undefined are not yet recruiting,
6 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in North York Diagnostic and Cardiac Centre,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in North York Diagnostic and Cardiac Centre, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 3 trials, and there were
also 0 trials that are defined as “Not Applicable".